Immune-Boosting shot offers new hope for women with recurrent miscarriages
NCT ID NCT03970954
Summary
This study tested whether a low-dose injection of a protein called IL-2 could help prevent miscarriage in women who have had multiple unexplained early pregnancy losses. The treatment aims to boost a specific type of calming immune cell that might help the mother's body better tolerate a pregnancy. Researchers gave the treatment to 18 women to see if it safely increased these protective cells in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MISCARRIAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bornes
Paris, Hopital Tenon, 75020, France
-
Kayem
Paris, Hopital Trousseau, 75012, France
-
Mekinian
Paris, Hopital Saint Antoine, 75012, France
Conditions
Explore the condition pages connected to this study.